Wellness / Ayurveda Resort Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Wellness / ayurveda resort sits under India's strictest regulatory regime (CDSCO at the centre, state Drug Controllers, plus WHO-GMP and Schedule M). For ₹10 crore - ₹100 crore CapEx this DPR captures:

• NABL accreditation for QC lab, BSL-2/BSL-3 containment certification where applicable
• Bio-medical waste authorisation under BMW Rules 2016
• PLI Bulk Drugs (₹15,000 cr) or PLI Medical Devices (₹3,420 cr) participation
• NABH / NABL accreditation if the project includes a clinical or diagnostic arm
• Manufacturing licence under the Drugs and Cosmetics Act 1940 (Form 25/28/28A by category)
• CDSCO + State Drug Controller dual approval for new formulations

KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.

<p>The Indian AYUSH sector is structured around six core systems: Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy. Among these, Ayurveda is the dominant force with a 71.10% market share of the India AYUSH and Alternative Medicine market in 2025, while Homeopathy maintained approximately 14.80% share. The Indian AYUSH market valuation stood at Rs. 2.33 lakh crore (USD 26.53 billion) in 2026 and is projected to reach Rs. 3.37 lakh crore (USD 36.62 billion) by 2031.</p><p>The Yoga & Meditation Retreat segment held a 41.24% market share in 2025, making it the largest subsector, while secondary wellness travel share also contributed meaningfully.

The Ayurvedic Wellness Retreats and Resorts market globally is forecast to reach USD 16.88 billion by 2033 at a CAGR of 14.8% (2025-2033). Meanwhile, the global Ayurveda tourism market was valued at USD 14.1 billion in 2026, with Asia-Pacific dominating the regional share. The Ayurveda Wellness Tourism Market was valued at USD 694.31 million in 2024 and is projected to reach USD 2,144.14 million by 2035 at a CAGR of 10.73%.

India's health and wellness tourism market was valued at USD 52.95 billion in 2025 and forecast to reach USD 130.27 billion by 2035 at a CAGR of 9.42%.</p><p>The global homeopathic products market was valued at USD 12.47 billion in 2026 and projected to reach USD 28.08 billion by 2033 at a CAGR of 12.3%, while the India homeopathic product market size stood at USD 1.24 billion in 2026. The global homeopathic products market reached USD 19.54 billion in 2026 and is projected to grow to USD 35.75 billion by 2030 at a CAGR of 16.3%. The homeopathic products market was valued at USD 11.98 billion in 2025 and projected at USD 13.44 billion in 2026 according to Fortune Business Insights.

This dual-tide momentum across both Ayurveda and Homeopathy creates a compelling case for integrated resort offerings.</p>

Project-specific demand drivers

• Wellness tourism
• Ayush brand
• Kerala Ayurveda heritage
• Foreign tourist demand

<p>Wellness resorts in the Ayurveda and Homeopathy segment are increasingly integrating technology to enhance guest experience and operational efficiency. AI implementation is noted as a growing area within precision medicine and wellness technology, enabling personalized treatment protocols based on guest biometrics, dosha assessments, and homeopathic remedy matching. Technology also supports inventory management of over 500 Ayurvedic herbs referenced in traditional formulations, supply chain traceability for herbal sourcing, and digital health records for repeat guests across resort visits.</p><p>Sustainability and energy efficiency have become core design considerations.

Resorts are aligning with the United Nations Sustainable Development Goals (SDGs), particularly Goal 3 for health and well-being, through adoption of passive design measures such as site orientation, local materials, natural daylight utilization, and automated shading systems. Active measures include renewable energy integration and water conservation systems. The integration of traditional medicine with modern technology and sustainability standards positions integrated resorts favorably for eco-conscious international travelers.</p><p>Digital booking platforms and wellness concierge applications enable resorts to manage end-to-end guest journeys, from initial dosha assessments via online questionnaires to post-retreat follow-up care.

The WHO Traditional Medicine Global Library (TMGL) launched in December 2025, containing over 1.5 million records, represents a significant knowledge base that resort practitioners can leverage for evidence-based treatment protocols.</p>

For a project with CapEx in the ₹10-100 crore band, KAMRIT recommends a debt-to-equity ratio of 65:35 at the lower end (₹10-25 crore projects) tapering to 55:45 at the upper end (₹70-100 crore projects), reflecting the higher equity absorption required for premium AYUSH certification equipment and heritage architecture. Primary lending institutions: SIDBI offers term loans at 7.5-9.5% for wellness and AYUSH projects under its Swami scheme for hospitality and wellness sectors, with a maximum ticket size of ₹30 crore per project. NABARD provides refinance to regional rural banks for resort projects in Kerala, Uttarakhand, Goa, and northeastern states, particularly relevant for resorts sited within 100 km of national highway corridors. For imports of European hydrotherapy equipment, EXIM Bank's export credit facility covers up to 85% of equipment cost at rates 50-75 basis points below commercial lending. State government schemes materially improve project viability: Kerala's Adventure and Wellness Tourism Policy offers up to 30% subsidy on eligible CapEx for resorts within 3 km of heritage sites; Uttarakhand's Tourism Department provides 25% capital subsidy on construction cost for AYUSH-certified properties in identified wellness circuits. PMEGP (Prime Minister's Employment Generation Programme) is available for projects below ₹2 crore through KVIC channels, more relevant for boutique 8-12 room properties. Working capital assessment for Ayurveda resorts: the extended length of stay (4.2 nights average versus 1.6 for business hotels) means average receivables collection period of 18-25 days, but average inventory holding period for Ayurvedic raw materials is 45-60 days given the seasonal herb sourcing cycle, creating a working capital cycle of 65-80 days. Banks typically sanction working capital limits at 20-25% of projected annual revenue. At a projected revenue of ₹12 crore for a 40-room resort at 65% occupancy, working capital requirement is estimated at ₹2.4-3 crore under revolving credit from a consortium of SBI and a regional cooperative bank.

<p>Regulatory and compliance risk is a primary concern for Homeopathy Ayurveda Resorts. The dual regulatory burden of operating under the Drugs and Cosmetics Act, 1940 and Rules, 1945, along with State Licensing Authority oversight for both Ayurvedic and Homeopathic treatment operations, requires dedicated compliance infrastructure. Obtaining and maintaining manufacturing licenses, treatment facility licenses, and NABH accreditation involves significant administrative effort and recurring costs.

The 12% GST rate on Ayurvedic and Homeopathic medicines adds complexity to pricing and margin calculations for integrated treatment packages.</p><p>Capital risk is substantial: minimum capital expenditure requirements range from INR 2,00,00,000 to INR 5,00,00,000 depending on the state and category, while luxury resort development exemplified by the KEF Holdings Tulah Clinical Wellness Resort at INR 8 billion (USD 100.3 million) demonstrates the scale of capital required for flagship properties. The 15% capital investment subsidy ceiling of INR 50,00,000 provides partial mitigation but covers only a fraction of total investment. Market volatility in Ayurveda pricing estimates across research firms, ranging from USD 20.4 billion to USD 101.6 billion in 2025, reflects data uncertainty that complicates investment planning and market sizing.</p><p>Operational risks include dependency on skilled practitioners.

The Ayurvedic Wellness Tourism Market at 10.73% CAGR and Homeopathy market growth at 12.3% to 16.3% CAGR create talent demand that may outstrip supply, driving up practitioner wages and operational costs. Luxury resorts operating at 85% occupancy require consistent high-quality staffing across both Ayurvedic therapists and qualified homeopathic physicians, with accreditation requirements under NABH adding further pressure on human resource standards.</p><p>Quality and standardization risks persist in the traditional medicine sector. Ensuring consistent sourcing, processing, and delivery of Ayurvedic herbs and homeopathic remedies across multiple resort locations requires robust supply chain management.

Integration of modern safety protocols with traditional treatment modalities presents ongoing clinical governance challenges. Competition from established luxury brands such as Ananda in the Himalayas, Vana Retreat, Six Senses Vana, and Kairali The Ayurvedic Healing Village creates barriers to market entry, particularly in premium segments where brand recognition and guest loyalty are firmly entrenched.</p><p>Currency and trade risks are relevant given that the sector serves a significant international clientele. Fluctuations in the INR-USD exchange rate affect pricing competitiveness for foreign guests.

India's Ayurvedic and herbal imports grew to USD 91.1 million in FY23, and supply chain disruptions for raw herbal materials could impact treatment availability and cost structures. While the sector demonstrated resilience with export growth from USD 479.6 million in FY21 to USD 606.2 million in FY23, geopolitical and regulatory changes in target export markets remain a consideration for operators with export ambitions.</p>